S&P 500   4,655.27
DOW   35,135.94
QQQ   399.69
S&P 500   4,655.27
DOW   35,135.94
QQQ   399.69
S&P 500   4,655.27
DOW   35,135.94
QQQ   399.69
S&P 500   4,655.27
DOW   35,135.94
QQQ   399.69

CareCloud Stock Forecast, Price & News

+0.09 (+1.30%)
(As of 11/29/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
68,256 shs
Average Volume
82,538 shs
Market Capitalization
$104.16 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for CareCloud and its competitors with MarketBeat's FREE daily newsletter.

CareCloud logo

About CareCloud

CareCloud, Inc. brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and make better business and care decisions. More than 40,000 providers across the United States count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Services and solutions include revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth, and patient experience management (PXM). CareCloud is headquartered in Somerset, NJ.


-$0.17 EPS Expected for CareCloud, Inc. (NASDAQ:MTBC) This Quarter
November 18, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Prepackaged software
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$105.12 million
Cash Flow
$0.32 per share
Book Value
$7.68 per share


Net Income
$-8.81 million
Pretax Margin




Free Float
Market Cap
$104.16 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.23 out of 5 stars

Medical Sector

341st out of 1,392 stocks

Prepackaged Software Industry

80th out of 265 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

CareCloud (NASDAQ:MTBC) Frequently Asked Questions

Is CareCloud a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareCloud in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CareCloud stock.
View analyst ratings for CareCloud
or view top-rated stocks.

How has CareCloud's stock been impacted by COVID-19 (Coronavirus)?

CareCloud's stock was trading at $5.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MTBC shares have increased by 31.8% and is now trading at $7.00.
View which stocks have been most impacted by COVID-19

Are investors shorting CareCloud?

CareCloud saw a drop in short interest in November. As of November 15th, there was short interest totaling 209,400 shares, a drop of 25.1% from the October 31st total of 279,400 shares. Based on an average daily volume of 68,500 shares, the short-interest ratio is presently 3.1 days. Currently, 2.3% of the company's stock are sold short.
View CareCloud's Short Interest

When is CareCloud's next earnings date?

CareCloud is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for CareCloud

How were CareCloud's earnings last quarter?

CareCloud, Inc. (NASDAQ:MTBC) posted its quarterly earnings data on Thursday, November, 4th. The technology company reported ($0.15) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.19) by $0.04. CareCloud had a negative net margin of 0.40% and a negative trailing twelve-month return on equity of 0.53%. During the same period in the prior year, the business earned ($0.46) earnings per share.
View CareCloud's earnings history

What guidance has CareCloud issued on next quarter's earnings?

CareCloud updated its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $135 million-$138 million, compared to the consensus revenue estimate of $135.03 million.

What price target have analysts set for MTBC?

3 equities research analysts have issued 1 year price targets for CareCloud's shares. Their forecasts range from $15.00 to $20.00. On average, they expect CareCloud's share price to reach $18.33 in the next twelve months. This suggests a possible upside of 161.9% from the stock's current price.
View analysts' price targets for CareCloud
or view top-rated stocks among Wall Street analysts.

What is Mahmud Haq's approval rating as CareCloud's CEO?

71 employees have rated CareCloud CEO Mahmud Haq on Glassdoor.com. Mahmud Haq has an approval rating of 47% among CareCloud's employees. This puts Mahmud Haq in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of CareCloud own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareCloud investors own include NVIDIA (NVDA), Inseego (INSG), JD.com (JD), Marvell Technology (MRVL), Niu Technologies (NIU), Bilibili (BILI), Alibaba Group (BABA), Baidu (BIDU), BioXcel Therapeutics (BTAI) and Baozun (BZUN).

What is CareCloud's stock symbol?

CareCloud trades on the NASDAQ under the ticker symbol "MTBC."

Who are CareCloud's major shareholders?

CareCloud's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include P.A.W. Capital Corp (4.69%), Franklin Resources Inc. (2.63%), Advisor Group Holdings Inc. (0.88%), Dimensional Fund Advisors LP (0.75%), Gabelli Funds LLC (0.71%) and UBS Group AG (0.42%). Company insiders that own CareCloud stock include A Hadi Chaudhry, Anne Busquet, Bill Korn, Cameron Munter, John N Daly, Kimberly J Blanche, Kimberly J Grant, Mahmud Ul Haq, Shruti H Patel and Stephen Andrew Snyder.
View institutional ownership trends for CareCloud

Which institutional investors are selling CareCloud stock?

MTBC stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, Citadel Advisors LLC, UBS Group AG, and BlackRock Inc.. Company insiders that have sold CareCloud company stock in the last year include A Hadi Chaudhry, Anne Busquet, Bill Korn, John N Daly, Mahmud Ul Haq, and Stephen Andrew Snyder.
View insider buying and selling activity for CareCloud
or view top insider-selling stocks.

Which institutional investors are buying CareCloud stock?

MTBC stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Gabelli Funds LLC, Franklin Resources Inc., P.A.W. Capital Corp, Advisor Group Holdings Inc., Morgan Stanley, and Marshall Wace LLP.
View insider buying and selling activity for CareCloud
or or view top insider-buying stocks.

How do I buy shares of CareCloud?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareCloud's stock price today?

One share of MTBC stock can currently be purchased for approximately $7.00.

How much money does CareCloud make?

CareCloud has a market capitalization of $104.16 million and generates $105.12 million in revenue each year. The technology company earns $-8.81 million in net income (profit) each year or ($0.77) on an earnings per share basis.

How many employees does CareCloud have?

CareCloud employs 3,700 workers across the globe.

What is CareCloud's official website?

The official website for CareCloud is www.carecloud.com.

Where are CareCloud's headquarters?

CareCloud is headquartered at 7 CLYDE ROAD, SOMERSET NJ, 08873.

How can I contact CareCloud?

CareCloud's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133 or via fax at 732-873-3378.

This page was last updated on 11/30/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.